SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

NRXP — NRx Pharmaceuticals, Inc.

NASDAQ

FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 17, 2026

REVENUE

$1.1M +3.1%

NET MARGIN

-1500.5% -1366.6 PTS

EPS

-$0.44 -895.5%

FREE CASH FLOW

-$9.8M -127.5%

No summary has been written for this call yet.